Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00285233 · ClinicalTrials.gov registry record · Phase 1
Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes
A Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT00285233 is a Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 8 participants.
The verdict
NCT00285233, a Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The objective of this study is to assess the safety and efficacy of islet allotransplantation for the reestablishment of stable glycemic control in patients with type 1 diabetes, using anti-thymocyte globulin induction immunosuppression with sirolimus, mycophenolate mofetil and low dose tacrolimus maintenance immunosuppression.
Interventions
- BIOLOGICAL Allogeneic islets of Langerhans transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2000-09 |
| Est. Completion | 2005-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00285233
The ClinicalTrials.gov registry entry for NCT00285233 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Allogeneic islets of Langerhans transplant is the first listed.
NCT00285233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00285233 about?
NCT00285233 is a clinical study titled "Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes". The objective of this study is to assess the safety and efficacy of islet allotransplantation for the reestablishment of stable glycemic control in patients with type 1 diabetes, using anti-thymocyte globulin induction immunosuppression with sirolimus, mycophenolate mofetil and low dose tacrolimus m...
What is the current status of trial NCT00285233?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2000-09. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00285233?
The interventions under investigation include: Allogeneic islets of Langerhans transplant (BIOLOGICAL).
Who is sponsoring clinical trial NCT00285233?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.